Evidence map›Paper›PMID 28692674›Full record

ArticlePloS one2017

Human brucellosis in Portugal-Retrospective analysis of suspected clinical cases of infection from 2009 to 2016.

Ana Pelerito, Rita Cordeiro, Rita Matos, Maria Augusta Santos, Sofia Soeiro, João Santos, Carla Manita, Carla Rio, M Santo, Eleonora Paixão and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Hunting for Answers: AssessingPathogens (Basel, Switzerland) · 2024
    Article
  3. Adaptation ofMicroorganisms · 2022
    Article
  4. Genetic Characterization ofFrontiers in microbiology · 2021
    Article
  5. Knockdown of MgExperimental and therapeutic medicine · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Interdisciplinary perspectives on infectious diseases · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ana PeleritoEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.ORCID http://orcid.org/0000-0003-4770-9079
Rita CordeiroEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.
Rita MatosImmunology Laboratory, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.
Maria Augusta SantosImmunology Laboratory, Department of Infectious Diseases, National Institute of Health, Porto, Portugal.
Sofia SoeiroImmunology Laboratory, Department of Infectious Diseases, National Institute of Health, Porto, Portugal.
João SantosImmunology Laboratory, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.
Carla ManitaImmunology Laboratory, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.
Carla RioImmunology Laboratory, Department of Infectious Diseases, National Institute of Health, Porto, Portugal.
M SantoImmunology Laboratory, Department of Infectious Diseases, National Institute of Health, Porto, Portugal.
Eleonora PaixãoAlentejo Regional Administration of Health, Nucleus of Support in the area of Statistics, Portugal.
Alexandra NunesBioinformatics Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.
Sofia NúncioEmergency Response and Biopreparedness Unit, Department of Infectious Diseases, National Institute of Health, Lisbon, Portugal.
National Institute of Health Dr. Ricardo Jorge · PTNational Statistical Institute of Portugal · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brucellosis is a zoonosis that is emerging in some regions of the world. Although brucellosis is a disease of obligatory declaration and is not eradicated in Portugal, no prevalence data is available in this country. In this study, we retrospectively analyzed the data available at the Reference Laboratory at the Portuguese National Institute of Health during the past 7 years (2009-2016) in order to get insight into the epidemiological scenario of brucellosis in Portugal. A total of 2313 biological samples from patients with clinical suspicion of brucellosis were subjected to immunological techniques for laboratory diagnosis. From 2010 to 2015, a subset of 259 samples was subjected to molecular methods. According to the available data, 167 out of 2313 (7.2%) samples had positive serology for Brucella spp. and 43 out of 259 samples (16.6%) were positive for B. melitensis by real time PCR, being classified as biovar 1 and 3. This study draws attention to the importance of integrating clinical and laboratory data of human cases in order to increase the efficacy of the response measures in case of outbreaks.

Indexed as

AdolescentAdultAgedAged, 80 and overBrucellosisChildFemaleHumansMaleMiddle AgedPortugalRetrospective StudiesYoung Adult

Identifiers

PMID28692674
PMCPMC5503191
OpenAlexW2735971734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.